EU's innovative medicines initiative homes in on efficacy and knowledge management
This article was originally published in Scrip
Executive Summary
Efficacy and knowledge management are to be the focus of Europe's Innovative Medicines Initiative's €160 million second call for proposals, said Jonathon Knowles, IMI deputy chairman at a press conference on Monday.